Missing periods in replicate designs [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2019-10-16 13:14 (347 d 13:31 ago) – Posting: # 20690
Views: 6,777

Dear all,

sometimes I see reports with a strange pattern of missing periods, e.g., subjects without the 1st period, subjects with only the 1st and the 4th, etc. Since I have only the statistical part of the report, I have no clue what was going on.
For the FDA’s RSABE only subjects with complete data (all periods) are used. But this is not the case for the EMA’s ABEL (all subjects with at least one T and R treatment for the calculation of the CI, all subjects with two R treatments for the calculation of CVwR).

I would say:Did you see cases like this? And if yes, do you know why?
I saw even cases where a subject in sequence TRTR had data only of periods 1 & 3. Useless.
Another case: 44 subjects had two administrations of T and R. However, 15 had two administrations of T and 39 two administrations of R. Chance – or what?

Dif-tor heh smusma 🖖
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

Activity
 Admin contact
21,079 posts in 4,396 threads, 1,468 registered users;
online 2 (0 registered, 2 guests [including 2 identified bots]).
Forum time: Monday 02:46 CEST (Europe/Vienna)

A central lesson of science is that to understand complex issues
(or even simple ones), we must try to free our minds of dogma and
to guarantee the freedom to publish, to contradict, and to experiment.
Arguments from authority are unacceptable.    Carl Sagan

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5